9960 — Kindstar Globalgene Technology Balance Sheet
0.000.00%
- HK$1.40bn
- HK$160.12m
- CNY927.57m
- 20
- 41
- 82
- 46
Annual balance sheet for Kindstar Globalgene Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 896 | 2,145 | 2,001 | 2,025 | 1,599 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 314 | 342 | 639 | 581 | 513 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,355 | 2,570 | 2,749 | 2,709 | 2,247 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 158 | 373 | 399 | 478 | 618 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,577 | 3,189 | 3,725 | 3,669 | 3,775 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 531 | 452 | 862 | 744 | 854 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3,421 | 469 | 899 | 797 | 991 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -1,844 | 2,720 | 2,827 | 2,872 | 2,784 |
Total Liabilities & Shareholders' Equity | 1,577 | 3,189 | 3,725 | 3,669 | 3,775 |
Total Common Shares Outstanding |